Cui, ChuanLiang
Lian, Bin
Zhang, XiaoShi
Wu, Di
Li, Ke
Si, Lu
Yang, Yue
Tian, Hui
Zhou, Li
Chi, ZhiHong
Sheng, XiNan
Kong, Yan
Mao, LiLi
Wang, Xuan
Bai, Xue
Yan, XieQiao
Li, SiMing
Dai, Jie
Tang, BiXia
Wei, Xiaoting
Gershenwald, Jeffrey E.
Balch, Charles M.
Guo, Jun
Funding for this research was provided by:
Beijing Municipal Administration of Hospitals’ Youth Programme (Code: QML20181101)
Beijing Municipal Administration of Hospitals Incubating Program (Code: PX2017042, PX2021046)
National Natural Science Foundation of China (No. 81972562)
Article History
Received: 28 December 2021
Accepted: 11 March 2022
First Online: 9 April 2022
Disclosure
: Dr. Jun Guo is the member of the advisory board/consultant of MSD, Roche, Pfizer, Bayer, Novartis, Simcere, Shanghai Junshi Bioscience, and Oriengene. Jeffrey E. Gershenwald has served as a consultant and/ or on advisory boards for Merck, Novartis, Bristol-Myers Squibb, Regeneron, Syndax, outside of the current work. Xue Bai declares a merit award supported by BMS. All remaining authors have declared no conflicts of interest.